Todos Medical Announce Kingcarlx as Brand Ambassador for the Tollovid #TolloUp Lifestyle Campaign
September 02, 2022 11:23 ET
|
Todos Medical Ltd.
Company also retains B2i Digital to enhance engagement with the investor community New York, NY, and Tel Aviv, ISRAEL, Sept. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd....
Todos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A Production
August 31, 2022 09:11 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Aug. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Expands COVID Onsite School Sample Collection to Include MonkeyPox Testing
August 29, 2022 09:15 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Aug. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces Saliva-Only MonkeyPox Testing at CLIA/CAP Clinical Lab Provista Diagnostics
August 26, 2022 07:18 ET
|
Todos Medical Ltd.
Lab Reaching Out to Georgia-based School Administrators to Assist with Outbreak Plans NEW YORK, NY and TEL AVIV, Israel, Aug. 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical,...
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
August 25, 2022 07:30 ET
|
Todos Medical Ltd.
Patient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune Long COVID Panel and Provista research-use-only MonkeyPox assays to assess effect of TPoxx...
Todos Medical Initiates MonkeyPox Diagnostic Case Studies After Being Approached by 4 Patients, Including 3 Women
August 23, 2022 09:14 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Aug. 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Reports Second Quarter 2022 Financial Results and Business Update Conference Call on Tuesday, August 23 at 8:30am ET
August 22, 2022 21:41 ET
|
Todos Medical Ltd.
Preparations for Tollovir™ Phase 2 Trial Extension to Support EUA Filing Now Complete Preparations for Tollovid™ Phase 2 Trial in Long COVID Now Complete Launch of New Suite of PCR Tests at...
Todos Medical Announces Commercialization of Lesion and Saliva-Based MonkeyPox PCR Testing
August 22, 2022 06:30 ET
|
Todos Medical Ltd.
Provista begins validation preparations for blood-based IgM/IgG MonkeyPox LDTCompany to release its Q2/2022 10Q quarterly report at 4:05 pm ET this afternoonCompany to host business update conference...
Todos Medical Announces Preprint of Data from First 100 Participants in IRB-waived Market Research Study of Supplementation with Tollovid in Long COVID
August 19, 2022 08:30 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID
August 15, 2022 09:48 ET
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...